Literature DB >> 26207211

Prognostic value of Twist in lung cancer: systematic review and meta-analysis.

Junli Zeng1, Ping Zhan1, Guannan Wu1, Wen Yang1, Wenjun Liang1, Tangfeng Lv1, Yong Song1.   

Abstract

BACKGROUND: Twist is identified as an epithelial-mesenchymal transition (EMT) regulator which has been considered to induce metastasis. However, the prognostic value of Twist in patients with lung cancer remains controversial.
METHODS: A search of database including EMBASE, Medline, ISI Web of knowledge and PubMed was performed. Eligible articles studying on the prognostic significance of Twist were included in this meta-analysis. Pooled hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) were assessed to quantify the prognostic role.
RESULTS: A total of five studies were included. The pooled HR for Twist was 1.949 (95% CI: 1.408-2.698, I(2)=42.7%, P<0.001), suggesting high Twist expression is associated with poor prognosis in lung cancer patients. Our sensitivity analyses suggested the robustness of the results. Neither Begg's test nor Egger's test found publication bias in any analysis.
CONCLUSIONS: Overexpressed Twist in lung cancer tissue indicated poor prognosis.

Entities:  

Keywords:  Twist; lung cancer; poor survival; prognosis

Year:  2015        PMID: 26207211      PMCID: PMC4483469          DOI: 10.3978/j.issn.2218-6751.2015.04.06

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  29 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

Authors:  Keun-Woo Lee; Jeong Hoon Kim; Songying Han; Chang-Ohk Sung; In-Gu Do; Young-Hyeh Ko; Sung Hee Um; Seok-Hyung Kim
Journal:  Ann Surg Oncol       Date:  2011-07-06       Impact factor: 5.344

4.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Authors:  Daniel R Rhodes; Shanker Kalyana-Sundaram; Vasudeva Mahavisno; Radhika Varambally; Jianjun Yu; Benjamin B Briggs; Terrence R Barrette; Matthew J Anstet; Colleen Kincead-Beal; Prakash Kulkarni; Sooryanaryana Varambally; Debashis Ghosh; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

5.  Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Authors:  Terence K Lee; Ronnie T P Poon; Anthony P Yuen; Ming Tat Ling; Wei Kei Kwok; Xiang Hong Wang; Yong Chuan Wong; Xin Yuan Guan; Kwan Man; King Lok Chau; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

6.  Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.

Authors:  Naoko Miura; Tokujiro Yano; Fumihiro Shoji; Daigo Kawano; Tomoyoshi Takenaka; Kensaku Ito; Yosuke Morodomi; Ichiro Yoshino; Yoshihiko Maehara
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

Review 7.  Epithelial-mesenchymal transition in development and cancer.

Authors:  Douglas S Micalizzi; Heide L Ford
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

Review 8.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

9.  Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.

Authors:  Yongli Shi; Hongyan Wu; Mingyi Zhang; Lei Ding; Fanqing Meng; Xiangshan Fan
Journal:  Diagn Pathol       Date:  2013-05-24       Impact factor: 2.644

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  9 in total

1.  SATB1 protein is associated with the epithelial‑mesenchymal transition process in non‑small cell lung cancers.

Authors:  Natalia Glatzel-Plucinska; Aleksandra Piotrowska; Adam Rzechonek; Marzenna Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Rep       Date:  2021-05-06       Impact factor: 3.906

2.  Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Saber Imani; Hossein Hosseinifard; Jingliang Cheng; Chunli Wei; Junjiang Fu
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

3.  Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.

Authors:  Xu Ji; Xing Guo; Yan Wang; Xiaotian Li; Hong Li
Journal:  Onco Targets Ther       Date:  2020-05-13       Impact factor: 4.147

Review 4.  Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond.

Authors:  Shing Yau Tam; Vincent W C Wu; Helen K W Law
Journal:  Front Oncol       Date:  2020-04-08       Impact factor: 6.244

5.  Prognostic and clinicopathological value of Twist expression in esophageal cancer: A meta-analysis.

Authors:  Wen-Peng Song; Su-Yan Wang; Si-Cheng Zhou; Dong-Sheng Wu; Jia-Yu Xie; Tong-Tong Liu; Xiu-Zhu Wu; Guo-Wei Che
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

Review 6.  Novel Molecular Markers for Breast Cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Biomark Cancer       Date:  2016-03-13

Review 7.  Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer.

Authors:  Trung Vu; Lin Jin; Pran K Datta
Journal:  J Clin Med       Date:  2016-04-11       Impact factor: 4.241

8.  Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies.

Authors:  Xianlu Zhuo; Huanli Luo; Aoshuang Chang; Dairong Li; Houyu Zhao; Qi Zhou
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

9.  Clinicopathological and prognostic significance of Twist overexpression in NSCLC.

Authors:  Meng Li; Xing Zhang; Xiaoqing Xu; Jiubin Wu; Kaiwen Hu; Xiuwei Guo; Peitong Zhang
Journal:  Oncotarget       Date:  2018-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.